<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0061">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Oliveira</surname>
    <given-names>O. V. D.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Gerd</surname>
    <given-names>B. R.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Andrew</surname>
    <given-names>S P.</given-names>
   </name>, &amp; 
   <name name-style="western">
    <surname>Luciano</surname>
    <given-names>T C.</given-names>
   </name>
  </person-group> (
  <year>2020</year>). 
  <article-title>Repurposing approved drugs as inhibitors of SARS-CoV-2 S-protein from molecular modeling and virtual screening</article-title>. 
  <source>
   <italic>Journal of Biomolecular Structure and Dynamics</italic>
  </source>, 
  <fpage>1</fpage>–
  <lpage>22</lpage>. 
  <pub-id pub-id-type="doi">10.1080/07391102.2020.1773318</pub-id>
 </mixed-citation>
</ref>
